Barclays Lowers Aspen Aerogels (NYSE:ASPN) Price Target to $25.00

Aspen Aerogels (NYSE:ASPN - Free Report) had its price target cut by Barclays from $27.00 to $25.00 in a research note published on Tuesday,Benzinga reports. They currently have an overweight rating on the construction company's stock.

Several other research firms have also commented on ASPN. StockNews.com upgraded shares of Aspen Aerogels to a "sell" rating in a report on Thursday, October 31st. Benchmark restated a "buy" rating and issued a $14.00 price target on shares of Aspen Aerogels in a report on Thursday, August 8th. Roth Mkm lowered their target price on shares of Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating for the company in a research note on Friday. Piper Sandler lowered their price objective on Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating for the company in a research report on Tuesday, October 22nd. Finally, HC Wainwright reissued a "buy" rating and issued a $30.00 price target on shares of Aspen Aerogels in a report on Wednesday, October 16th. One analyst has rated the stock with a sell rating, nine have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Aspen Aerogels presently has an average rating of "Moderate Buy" and a consensus price target of $28.70.

Aspen Aerogels Trading Down 8.5 %

ASPN stock traded down $1.46 during trading on Tuesday, hitting $15.80. The company had a trading volume of 3,640,419 shares, compared to its average volume of 1,582,738. The company has a quick ratio of 2.82, a current ratio of 3.46 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $1.22 billion, a P/E ratio of 1,588.59 and a beta of 2.21. The company has a 50 day simple moving average of $22.87 and a 200-day simple moving average of $24.74. Aspen Aerogels has a 52-week low of $8.79 and a 52-week high of $33.15.

Insiders Place Their Bets

In other news, CEO Donald R. Young sold 63,355 shares of the company's stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the transaction, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm's stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the sale, the chief financial officer now owns 20,790 shares of the company's stock, valued at approximately $626,610.60. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Donald R. Young sold 63,355 shares of the company's stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the transaction, the chief executive officer now directly owns 483,640 shares of the company's stock, valued at $14,523,709.20. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is owned by insiders.

Institutional Trading of Aspen Aerogels

Several institutional investors and hedge funds have recently made changes to their positions in the company. Point72 Hong Kong Ltd purchased a new stake in Aspen Aerogels during the 2nd quarter valued at approximately $84,000. nVerses Capital LLC purchased a new position in Aspen Aerogels in the 2nd quarter valued at $95,000. Quent Capital LLC purchased a new position in Aspen Aerogels during the third quarter worth about $118,000. Point72 DIFC Ltd purchased a new stake in Aspen Aerogels in the 2nd quarter valued at approximately $121,000. Finally, Public Employees Retirement Association of Colorado purchased a new position in shares of Aspen Aerogels during the 2nd quarter worth approximately $145,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.